NeoX Biotech

About:

NeoX Biotech is a pharmaceutical company engaged in early-stage drug developmentbased on AI and computational biophysical technology.

Website: https://www.neoxbiotech.com

Top Investors: HongShan, Morningside Venture Investments, Sky9 Capital, Vertex Ventures China, LYFE Capital

Description:

NeoX Biotech is a biotechnology company combining AI with biophysics to advance drug research and development. NeoX Biotech is dedicated to the discovery and development of macromolecular and multispecific drugs, particularly in the field of immuno-oncology. NeoX Biotech develops a platform for early therapeutic discovery by characterizing protein-protein interactions.

Total Funding Amount:

$40M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2018-01-01

Contact Email:

info(AT)neoxbiotech.com

Founders:

Michael Chen

Number of Employees:

11-50

Last Funding Date:

2021-07-08

IPO Status:

Private

© 2024 MyAiNote.com